LYSSIENT Trademark

Trademark Overview

On Tuesday, July 24, 2012, a trademark application was filed for LYSSIENT with the United States Patent and Trademark Office. The USPTO has given the LYSSIENT trademark a serial number of 79116610. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, July 24, 2022. This trademark is owned by Boehringer Ingelheim International GmbH. The LYSSIENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
lyssient

General Information

Serial Number79116610
Word MarkLYSSIENT
Filing DateTuesday, July 24, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, July 24, 2022
Registration Number4340524
Registration DateTuesday, May 28, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events

Event DateEvent Description
Friday, March 10, 2023UNDELIVERABLE MAIL - NO ACTION TAKEN
Sunday, February 19, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, February 19, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, October 24, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, September 29, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, September 29, 2020INVALIDATION PROCESSED
Thursday, September 3, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 3, 2020CANCELLED SECTION 71
Sunday, September 22, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, September 4, 2013FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 4, 2013FINAL DISPOSITION PROCESSED
Wednesday, August 28, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 28, 2013REGISTERED-PRINCIPAL REGISTER
Monday, April 22, 2013NOTIFICATION PROCESSED BY IB
Tuesday, March 12, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 20, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 20, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 20, 2013NOTICE OF PUBLICATION
Monday, February 4, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, February 2, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 30, 2013AMENDMENT FROM APPLICANT ENTERED
Wednesday, January 30, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 24, 2013ASSIGNED TO LIE
Tuesday, January 22, 2013PAPER RECEIVED
Wednesday, December 12, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 15, 2012REFUSAL PROCESSED BY IB
Monday, October 22, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 22, 2012REFUSAL PROCESSED BY MPU
Monday, October 22, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, October 21, 2012NON-FINAL ACTION WRITTEN
Wednesday, October 17, 2012ASSIGNED TO EXAMINER
Saturday, September 15, 2012APPLICATION FILING RECEIPT MAILED
Tuesday, September 11, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 10, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, September 7, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

lyssient system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary